Your Advocates Ltd’s NeoGenomics NEO Stock Holding History

Your Advocates Ltd’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-241	Closed	-$13K	–	147
2020 Q4	$13K	Hold	241	–	–	0.01%	79
2020 Q3	$9K	Hold	241	–	–	0.01%	83
2020 Q2	$8K	Hold	241	–	–	0.01%	87
2020 Q1	$7K	Buy	+241	New	+$7.22K	0.01%	78

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Your Advocates Ltd's NEO Position: Q1 2021 in Review

Your Advocates Ltd sold out of NeoGenomics (NEO) in Q1 2021, closing a stake of 241 shares — an estimated $13K sold.

Your Advocates Ltd first reported a position in NEO in Q1 2020 and held it in 4 quarters. The position peaked at $13K in Q4 2020. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.

Your Advocates Ltd reported no remaining NeoGenomics position as of Q1 2021 after selling out during the quarter.
Your Advocates Ltd sold 241 NeoGenomics shares in Q1 2021, an estimated $13K.
Your Advocates Ltd first reported a position in NeoGenomics in Q1 2020 and held it in 4 quarters.
Your Advocates Ltd's NeoGenomics position peaked at $13K in Q4 2020.
332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.

Based on Your Advocates Ltd's 13F filing for Q1 2021, filed 29 Apr 2021.